Get the Stockscreener App
15.17
2.57%
0.38
Coeptis Therapeutics Holdings Inc stock is traded at $15.17, with a volume of 32,399.
It is up +2.57% in the last 24 hours and down -3.38% over the past month.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
See More
Previous Close:
$14.79
Open:
$15
24h Volume:
32,399
Relative Volume:
0.50
Market Cap:
$81.01M
Revenue:
-
Net Income/Loss:
$-11.62M
P/E Ratio:
-2.7089
EPS:
-5.6
Net Cash Flow:
$-6.91M
1W Performance:
+3.20%
1M Performance:
-3.38%
6M Performance:
+101.19%
1Y Performance:
+116.41%
1-Day Range:
$14.60
$15.25
1-Week Range:
$13.88
$15.25
52-Week Range:
$3.80
$21.41
Coeptis Therapeutics Holdings Inc Stock (COEP) Company Profile
Name
Coeptis Therapeutics Holdings Inc
Sector
Industry
Phone
724-934-6467
Address
105 BRADFORD ROAD, SUITE 420, WEXFORD
Compare COEP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
COEP
COEPTIS THERAPEUTICS INC
|
6.99 | 2.70M | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.83 | 372.90M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
4.82 | 418.21M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
SHMD
Schmid Group N V
|
7.30 | 329.86M | 0 | 0 | 0 | 0.00 |
|
DWLD
Davis Select Worldwide ETF
|
48.05 | 0 | 0 | 0 | 0 | 0.00 |
|
QQQE
Direxion NASDAQ-100 Equal Weigh
|
105.25 | 0 | 0 | 0 | 0 | 0.00 |
Coeptis Therapeutics Holdings Inc Stock (COEP) Latest News
Will Coeptis Therapeutics Holdings Inc. Equity Warrant stock benefit from AI adoption2026 world cup usa national team third place match playmakers pressing system group prediction tactical review - Улправда
Precision Trading with Coeptis Therapeutics Holdings Inc. (COEP) Risk Zones - Stock Traders Daily
Coeptis Therapeutics S-4 declared effective by SEC - marketscreener.com
Coeptis Therapeutic Holdings Details $835M Transaction Structure with Z-Squared; Vanderbilt Report Publishes Coverage - The Globe and Mail
Coeptis Therapeutics Holdings, Inc. Announces SEC Approval of Merger Registration Statement with Z Squared Inc. - Quiver Quantitative
SEC clears Coeptis merger proxy as shareholders prepare to vote - Stock Titan
Coeptis Therapeutics (NASDAQ:COEP) Trading Up 2.7%Still a Buy? - MarketBeat
Coeptis Therapeutics (NASDAQ:COEP) Trading Up 2.7% – Still a Buy? - Defense World
Can Coeptis Therapeutics Holdings Inc. Equity Warrant stock continue upward trendBearish Engulfing Patterns & Free Trading Signals to Sharpen Your Edge - bollywoodhelpline.com
Can Coeptis Therapeutics Holdings Inc. Equity Warrant stock attract ESG capital inflowsCurrency Fluctuation Impact & Low Entry Investment Ideas - bollywoodhelpline.com
How Coeptis Therapeutics Holdings Inc. (COEP) Affects Rotational Strategy Timing - Stock Traders Daily
Coeptis Therapeutics Holdings Inc. Warrant 2022-28.10.2027 on Coeptis Therapeutics Holdings Inc. - TradingView — Track All Markets
Will Coeptis Therapeutics Holdings Inc. stock outperform growth indexesMarket Sentiment Summary & Consistent Return Strategy Ideas - Улправда
Can Coeptis Therapeutics Holdings Inc. stock maintain growth trajectoryJuly 2025 Patterns & Stepwise Entry and Exit Trade Signals - Улправда
How Coeptis Therapeutics Holdings Inc. stock compares to market leaders2025 Major Catalysts & High Accuracy Swing Entry Alerts - Улправда
Downgrade Watch: Will Coeptis Therapeutics Holdings Inc. Equity Warrant stock benefit from AI adoptionJuly 2025 Fed Impact & Long-Term Safe Investment Plans - Улправда
Is Coeptis Therapeutics Holdings Inc. Equity Warrant stock undervalued vs historical averagesJuly 2025 Retail & Reliable Entry Point Trade Alerts - Улправда
Is Coeptis Therapeutics Holdings Inc. Equity Warrant stock resilient to inflationInsider Selling & Entry Point Strategy Guides - Улправда
Can Coeptis Therapeutics Holdings Inc. stock surprise with earnings upsideTrend Reversal & AI Forecasted Entry/Exit Points - ulpravda.ru
Why Coeptis Therapeutics Holdings Inc. Equity Warrant stock is favored by top institutionsJuly 2025 Drop Watch & Safe Investment Capital Preservation Plans - Улправда
Will Coeptis Therapeutics Holdings Inc. stock benefit from infrastructure spending2025 Technical Patterns & Free Weekly Chart Analysis and Trade Guides - Улправда
Momentum Shift: Will Coeptis Therapeutics Holdings Inc. Equity Warrant stock split attract more investorsIPO Watch & Pattern Based Trade Signal System - Улправда
Will Coeptis Therapeutics Holdings Inc. Equity Warrant stock split attract more investors2025 Historical Comparison & Fast Moving Trade Plans - Улправда
Will Coeptis Therapeutics Holdings Inc. stock reach all time highs in 2025Portfolio Update Report & Community Driven Trade Alerts - DonanımHaber
What makes Coeptis Therapeutics Holdings Inc. Equity Warrant stock attractive to growth fundsTrade Risk Assessment & Free Low Drawdown Momentum Trade Ideas - DonanımHaber
Why Coeptis Therapeutics Holdings Inc. Equity Warrant stock remains undervaluedEntry Point & Growth Oriented Trade Recommendations - Улправда
Earnings Update: Can Coeptis Therapeutics Holdings Inc. stock surprise with earnings upside2025 Key Highlights & Trade Opportunity Analysis - Улправда
Aug Reactions: Will Coeptis Therapeutics Holdings Inc. stock outperform growth indexesJuly 2025 Price Swings & Weekly Stock Breakout Alerts - Улправда
Is Coeptis Therapeutics Holdings Inc. Equity Warrant stock a contrarian buyJuly 2025 PostEarnings & Verified Swing Trading Watchlists - Улправда
How Coeptis Therapeutics Holdings Inc. Equity Warrant stock performs in rising dollar environment2025 AllTime Highs & Expert Verified Movement Alerts - Улправда
Trend Review: Is Coeptis Therapeutics Holdings Inc. Equity Warrant stock a contrarian buyJuly 2025 Earnings & Fast Entry Momentum Trade Alerts - ulpravda.ru
Why Coeptis Therapeutics Holdings Inc. Equity Warrant stock is considered a top pickInflation Watch & AI Enhanced Trading Signals - Улправда
Will Coeptis Therapeutics Holdings Inc stock reach all time highs in 2025 - moha.gov.vn
Discipline and Rules-Based Execution in COEP Response - Stock Traders Daily
Investment Review: Can Coeptis Therapeutics Holdings Inc stock sustain revenue growthInsider Buying & Daily Stock Momentum Reports - moha.gov.vn
Coeptis Therapeutics (NASDAQ:COEP) Stock Price Down 3.6% – Time to Sell? - Defense World
Coeptis Therapeutics (NASDAQ:COEP) Stock Price Down 3.6%Time to Sell? - MarketBeat
Coeptis Therapeutics Holdings Inc Equity Warrant Stock Analysis and ForecastValue Traps to Avoid & Low Entry Investment Growth - earlytimes.in
Buyout Rumor: Can Coeptis Therapeutics Holdings Inc stock beat analyst upgradesJuly 2025 Gainers & Target Return Focused Stock Picks - moha.gov.vn
Is Coeptis Therapeutics Holdings Inc. stock resilient to inflation2025 Stock Rankings & AI Forecasted Stock Moves - Newser
Behavioral Patterns of COEP and Institutional Flows - news.stocktradersdaily.com
Is Coeptis Therapeutics Holdings Inc. stock oversold or undervaluedJuly 2025 Selloffs & Safe Entry Momentum Tips - Newser
Coeptis Therapeutics (COEP) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Why hedge funds are buying Coeptis Therapeutics Holdings Inc. Equity Warrant stockTrade Ideas & Verified Chart Pattern Trade Signals - Newser
Why analysts upgrade Coeptis Therapeutics Holdings Inc. stockBuy Signal & Community Verified Trade Alerts - Newser
Coeptis Therapeutics Holdings Inc Stock (COEP) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.52%
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):